top of page
  • Facebook
  • Twitter
  • Instagram
Roden Headshot.jpg

Dan Roden, MD
Professor,  Department of Medicine & Pharmacology
Vanderbilt University Medical Center

Pharmacogenomics and Psychiatry
Saturday, February 13, 2027
4:45 PM - 5:45 PM

Dan Roden grew up in Montreal and received his medical degree and trained in Internal Medicine at McGill University. He then went to Vanderbilt where, after fellowships in Clinical Pharmacology and Cardiology, he joined the faculty. His research program studies how genetic variation affects human disease susceptibility, and his special interests are pharmacogenetics, and the genetic determinants of abnormal heart rhythms, especially those induced by drugs. 

​

After serving as chief of the division of Clinical Pharmacology for 12 years, he was tasked in 2006 with leading Vanderbilt’s efforts in Personalized Medicine. Under his leadership, Vanderbilt has become internationally-recognized for cutting edge programs in this area, including the large (>350,000 samples) biobank BioVU and the EHR-based preemptive pharmacogenetic program PREDICT. He served as Principal Investigator for the Vanderbilt site of the Pharmacogenomics Research Network (2001-2021), and currently serves as co-PI for the Vanderbilt site of the Electronic Medical Records and Genomics (eMERGE) Network (2007-), the genomic Learning Healthcare System (2024-) network, and the Data and Research Center for the US NIH All of Us program (2020-). Dr. Roden has received the American Society for Clinical Pharmacology and Therapeutics’ Leon Goldberg Young Investigator Award, Rawls Palmer Progress in Science Award, the Oscar Hunter Career Award, and the Mentor Award; the Distinguished Scientist Award, the Douglas Zipes lectureship, the Ralph Lazzara Lectureship, and the Gordon Moe Lectureship from the Heart Rhythm Society; the Distinguished Scientist Award and the inaugural Functional Genomics and Translational Biology Medal of Honor from the American Heart Association; the Alumnus Lifetime Achievement Award and the Louis and Artur Lucian Award in Cardiovascular Research from McGill; and the Jay and Jeanie Schottenstein prize in cardiovascular sciences from the Ohio State University. He has been elected to membership in the American Society for Clinical Investigation and the Association of American Physicians, and fellowship in the American Association for the Advancement of Science.
 

Lecture Summary:

This presentation will review mechanisms underlying variable drug effects and the current understanding of the role of common and rare genetic variants in variable drug actions.

​Goals and Learning Objectives:

  • Review mechanisms underlying variable drug effects

  • Review current understanding of the role of common and rare genetic variants in variable drug action

Disclosures:

No relevant disclosures to provide.

bottom of page